What published research actually says about BPC-157 and TB-500 — sequences, study models, human-evidence gaps, and why no combination study exists.
Deep dive on GLP-1 receptor agonism — binding affinities, signaling cascades, GIP/GLP-1 dual agonism, and triple-agonist research from 2024–2026 literature.
SLU-PP-332 ERRα agonist deep dive — mechanism, the 2023 Saint Louis University publication, exercise-mimetic transcriptional signature, and 2024-2026 follow-up research.
Pillar guide to longevity research peptides — MOTS-C, SLU-PP-332, GHK-Cu, 5-Amino-1MQ — mechanisms, 2024–2026 data, and comparative pharmacology.
Side-by-side comparison of CJC-1295 (DAC-modified GHRH) and Sermorelin (native GHRH 1-29) — pharmacokinetics, pulsatility, receptor complementarity, and research applications.